-
Je něco špatně v tomto záznamu ?
Medical and economic burden of influenza in the elderly population in central and eastern European countries
G. Kovács, Z. Kaló, K. Jahnz-Rozyk, J. Kyncl, A. Csohan, A. Pistol, M. Leleka, R. Kipshakbaev, L. Durand, B. Macabeo,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2012 do Před 1 rokem
PubMed Central
od 2012 do Před 1 rokem
Europe PubMed Central
od 2012 do Před 1 rokem
PubMed
24165394
DOI
10.4161/hv.26886
Knihovny.cz E-zdroje
- MeSH
- chřipka lidská ekonomika epidemiologie MeSH
- incidence MeSH
- lidé MeSH
- náklady na zdravotní péči * MeSH
- prevalence MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vakcinace využití MeSH
- vakcíny proti chřipce aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (> 65 y) is often low in Central and Eastern Europe (CEE); potentially because a paucity of country-specific data limits evidence-based policy making. Therefore the medical and economic burden of influenza were estimated in elderly populations in the Czech Republic, Hungary, Kazakhstan, Poland, Romania, and Ukraine. Data covering national influenza vaccination policies, surveillance and reporting, healthcare costs, populations, and epidemiology were obtained via literature review, open-access websites and databases, and interviews with experts. A simplified model of patient treatment flow incorporating cost, population, and incidence/prevalence data was used to calculate the influenza burden per country. In the elderly, influenza represented a large burden on the assessed healthcare systems, with yearly excess hospitalization rates of ~30/100,000. Burden varied between countries and was likely influenced by population size, surveillance system, healthcare provision, and vaccine coverage. The greatest burden was found in Poland, where direct costs were over EUR 5 million. Substantial differences in data availability and quality were identified, and to fully quantify the burden of influenza in CEE, influenza reporting systems should be standardized. This study most probably underestimates the real burden of influenza, however the public health problem is recognized worldwide, and will further increase with population aging. Extending influenza vaccination of the elderly may be a cost-effective way to reduce the burden of influenza in CEE.
1 Ya Horbachevsky Ternopil State Medical University
Bela Johan National Center for Epidemiology
Department of Infectious Diseases Epidemiology
Military Institute of Medicine
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014586
- 003
- CZ-PrNML
- 005
- 20150427110404.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4161/hv.26886 $2 doi
- 035 __
- $a (PubMed)24165394
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kovács, Gábor $u Syreon Research Institute; Budapest, Hungary.
- 245 10
- $a Medical and economic burden of influenza in the elderly population in central and eastern European countries / $c G. Kovács, Z. Kaló, K. Jahnz-Rozyk, J. Kyncl, A. Csohan, A. Pistol, M. Leleka, R. Kipshakbaev, L. Durand, B. Macabeo,
- 520 9_
- $a Influenza affects 5-15% of the population during an epidemic. In Western Europe, vaccination of at-risk groups forms the cornerstone of influenza prevention. However, vaccination coverage of the elderly (> 65 y) is often low in Central and Eastern Europe (CEE); potentially because a paucity of country-specific data limits evidence-based policy making. Therefore the medical and economic burden of influenza were estimated in elderly populations in the Czech Republic, Hungary, Kazakhstan, Poland, Romania, and Ukraine. Data covering national influenza vaccination policies, surveillance and reporting, healthcare costs, populations, and epidemiology were obtained via literature review, open-access websites and databases, and interviews with experts. A simplified model of patient treatment flow incorporating cost, population, and incidence/prevalence data was used to calculate the influenza burden per country. In the elderly, influenza represented a large burden on the assessed healthcare systems, with yearly excess hospitalization rates of ~30/100,000. Burden varied between countries and was likely influenced by population size, surveillance system, healthcare provision, and vaccine coverage. The greatest burden was found in Poland, where direct costs were over EUR 5 million. Substantial differences in data availability and quality were identified, and to fully quantify the burden of influenza in CEE, influenza reporting systems should be standardized. This study most probably underestimates the real burden of influenza, however the public health problem is recognized worldwide, and will further increase with population aging. Extending influenza vaccination of the elderly may be a cost-effective way to reduce the burden of influenza in CEE.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 12
- $a náklady na zdravotní péči $7 D017048
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a vakcíny proti chřipce $x aplikace a dávkování $7 D007252
- 650 _2
- $a chřipka lidská $x ekonomika $x epidemiologie $7 D007251
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a vakcinace $x využití $7 D014611
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kaló, Zoltán $u Syreon Research Institute; Budapest, Hungary.
- 700 1_
- $a Jahnz-Rozyk, Karina $u Military Institute of Medicine; Warsaw, Poland.
- 700 1_
- $a Kyncl, Jan $u National Institute of Public Health; Department of Infectious Diseases Epidemiology; Prague, Czech Republic.
- 700 1_
- $a Csohan, Agnes $u Bela Johan National Center for Epidemiology; Budapest, Hungary.
- 700 1_
- $a Pistol, Adriana $u National Institute of Public Health; Bucuresti, Romania.
- 700 1_
- $a Leleka, Mariya $u I. Ya.Horbachevsky Ternopil State Medical University; Ternopil, Ukraine.
- 700 1_
- $a Kipshakbaev, Rafail $u ISPOR Chapter Kazakhstan; Astana, Kazakhstan.
- 700 1_
- $a Durand, Laure $u Sanofi Pasteur; Lyon, France.
- 700 1_
- $a Macabeo, Bérengère $u Sanofi Pasteur; Lyon, France.
- 773 0_
- $w MED00181409 $t Human vaccines & immunotherapeutics $x 2164-554X $g Roč. 10, č. 2 (2014), s. 428-40
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24165394 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20150427110708 $b ABA008
- 999 __
- $a ok $b bmc $g 1072167 $s 897464
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 10 $c 2 $d 428-40 $i 2164-554X $m Human vaccines & immunotherapeutics $n Hum Vaccin Immunother $x MED00181409
- LZP __
- $a Pubmed-20150420
